Philippine Customs Seizes 500g Cocaine Worth Php2.65M in Davao City

Nov.24.2022

The Philippine Customs Bureau seized cocaine worth 2.65 million pesos in a joint operation with other agencies in Davao City.

An official announced yesterday that the Bureau of Customs (BOC) confiscated cocaine and other items worth 2.65 million pesos (approximately 33,350 RMB) in an operation in the city of Davao on Tuesday.

Customs Commissioner Yogi Filemon Ruiz reported that customs agents, along with the Philippine Drug Enforcement Agency (PDEA) and the National Intelligence Coordinating Agency, conducted a raid at the AFP-RSBS Industrial Park where they seized 500 grams of cocaine, electronic pods containing cannabis oil, and other drug paraphernalia. Ruiz stated that the evidence will be turned over to the PDEA.

Statement:

This article is compiled from third-party information and is provided for industry professionals for the purpose of knowledge sharing and learning.

This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity or accuracy of its content. The translation of this article is only intended for industry research and communication purposes.

Due to limitations in translation ability, the translated article may not fully reflect the original text. Please refer to the original text for accuracy.

2FIRSTS is fully aligned with the Chinese government's positions and statements on all domestic issues, as well as those related to Hong Kong, Macau, Taiwan, and international matters.

The compilation of this information belongs to the original media and author, and if there is any infringement, please contact us for deletion.

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

EVO NXT European Tobacco & NGP Exhibition

EVO NXT European Tobacco & NGP Exhibition

Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements

Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements

A Fifth Circuit panel upheld the U.S. Food and Drug Administration’s 2021 final rule requiring companies seeking premarket authorization for new tobacco products to include information on health-risk investigations. In a published opinion, the court found FDA satisfied the Regulatory Flexibility Act’s procedural requirements and reasonably relied on the economic analysis from the 2016 “deeming rule” as a factual basis to certify limited impact on small businesses.

Feb.27 by 2FIRSTS.ai

Guernsey Rejects Petition to Overturn Under-18 Vape Shop Ban

Guernsey Rejects Petition to Overturn Under-18 Vape Shop Ban

A petition seeking to overturn a new ban on under-18s entering vape shops in Guernsey has been rejected. The Health and Social Care Committee said the measure meets its objective of protecting children from exposure to vaping products.

Mar.23 by 2FIRSTS.ai

Spain’s Nicotine Pouch Sales Reached 5 Million Cans in 2025, Industry Says 2026 Could Hit 8 Million

Spain’s Nicotine Pouch Sales Reached 5 Million Cans in 2025, Industry Says 2026 Could Hit 8 Million

Spain’s Nicotine Pouch Association said nicotine pouch sales in Spain reached 5 million cans of 20 units in 2025 and are expected to rise 60% to 8 million in 2026. The group said there are currently 20 to 30 brands on the Spanish market and called for regulation proportionate to product risk. It also opposed a proposal to reduce nicotine content to 0.99 mg per pouch, saying it would amount to a de facto ban on the category.

Mar.19 by 2FIRSTS.ai

Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year

Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year

FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.

Apr.23 by 2FIRSTS.ai

BAT faces London shareholder lawsuit over alleged disclosure failures tied to North Korea business

BAT faces London shareholder lawsuit over alleged disclosure failures tied to North Korea business

British American Tobacco is facing a shareholder lawsuit in London alleging it failed to properly disclose to markets information about breaches of U.S. sanctions linked to its North Korea-related business. BAT agreed in 2023 to pay more than $635 million to U.S. authorities after a subsidiary admitted conspiring to violate U.S. sanctions by selling tobacco products to North Korea and committing bank fraud from 2007 to 2017.

Mar.05 by 2FIRSTS.ai

West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements

West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements

West Virginia’s House of Delegates passed the Vape Safety Act of 2026, a proposal to tighten oversight of vape and smoke shops through licensing, fees and enforcement. The bill would establish a state directory requiring vape products sold in West Virginia to have FDA marketing authorization or a pending application under FDA review to be listed, and only directory-listed products could be sold starting Sept. 1, 2026 if enacted.

Feb.28 by 2FIRSTS.ai

Related Topics

News

Related Read

Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements

Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements

Guernsey Rejects Petition to Overturn Under-18 Vape Shop Ban

Guernsey Rejects Petition to Overturn Under-18 Vape Shop Ban

Spain’s Nicotine Pouch Sales Reached 5 Million Cans in 2025, Industry Says 2026 Could Hit 8 Million

Spain’s Nicotine Pouch Sales Reached 5 Million Cans in 2025, Industry Says 2026 Could Hit 8 Million

Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year

Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year

BAT faces London shareholder lawsuit over alleged disclosure failures tied to North Korea business

BAT faces London shareholder lawsuit over alleged disclosure failures tied to North Korea business

West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements

West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements